Jpmorgan Chase & CO Novo Cure LTD Call Options Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NVCR
# of Institutions
265Shares Held
78.6MCall Options Held
751KPut Options Held
293K-
Black Rock Inc. New York, NY12.1MShares$202 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA11.7MShares$194 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.1MShares$185 Million0.0% of portfolio
-
Nordwand Advisors, LLC Radnor, PA3.03MShares$50.4 Million12.67% of portfolio
-
State Street Corp Boston, MA3.01MShares$50 Million0.0% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.74B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...